The Oklahoma Parent-Child Assistance Program
Launched by UNIVERSITY OF OKLAHOMA · Sep 7, 2022
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
The Oklahoma Parent-Child Assistance Program (PCAP) is a clinical trial aimed at helping mothers who have used drugs or alcohol during pregnancy. This program offers support over three years, with trained case managers working closely with mothers in their homes to help them set goals and connect with community resources. The main goals are to assist mothers in getting treatment for substance use disorders, promote recovery, and prevent future substance use during pregnancy. This study is particularly important because it is the first time PCAP will be available in Oklahoma, a state with a high number of women facing legal issues related to drug use.
To be eligible for the trial, women must be 18 years or older, have used alcohol, opioids, or other drugs during pregnancy, and currently live in either Oklahoma City or Tulsa. Participants can expect to be part of a supportive program that helps them improve their lives and the lives of their children. The trial will include about 200 women, with half receiving the PCAP services and the other half not receiving these specific services for comparison. Researchers will evaluate various outcomes, such as whether mothers achieve sobriety, maintain healthy family lives, and avoid legal troubles.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Women who have used alcohol, opioids, or other drugs during pregnancy
- • Women who are (1) pregnant or have a child under 24 months old who was exposed to substances and are not well connected to community services or (2) have a child with fetal Alcohol Spectrum Disorder and are currently with at-risk alcohol use and in childbearing years
- • Resides in Oklahoma City, Oklahoma or Tulsa, Oklahoma
- Exclusion Criteria:
- • Not meeting eligible criteria above
- • Incarcerated at the time of enrollment
- • Enrollment in similar services (i.e., ReMerge, Systems of Care (SOC) and/or Family Treatment Courts (FTC) and heading to Termination of Parental Rights (TPR))
- • If the participant is receiving services from the Substance use Treatment and Recovery (STAR) Prenatal Clinic and is part of the research, their enrollment in PCAP will be delayed until STAR Prenatal Clinic graduation
About University Of Oklahoma
The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oklahoma City, Oklahoma, United States
Tulsa, Oklahoma, United States
Patients applied
Trial Officials
Erin Maher, Ph.D.
Principal Investigator
University of Oklahoma
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials